SCHEMBL29620869

SCHEMBL29620869

N#Cc1ccc(Nc2ncc(-c3ccc(C(F)(F)F)cn3)o2)nn1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TRPV1 Q8NER1 8/20 0.34
CCR6 P51684 1/20 0.34
KDR P35968 3/20 0.33
FLT1 P17948 2/20 0.33
FLT4 P35916 2/20 0.33
PTGS1 P23219 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KIF11 P52732 1/20 0.31
IKBKE Q14164 1/20 0.31
TBK1 Q9UHD2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24636937 1.00 NPSR1 (0.39) NPSR1KDM4ETRPV1CCR6KDR
SCHEMBL22926082 0.86 TRPV1 (0.47) TRPV1CCR6KDRFLT1FLT4
SCHEMBL22925935 0.85 CHEK1 (0.38) NPSR1KDM4ETRPV1CCR6KDR
SCHEMBL22925604 0.85 KDR (0.35) KDRFLT1FLT4NPC1RAB9A
SCHEMBL22925932 0.83 CHEK1 (0.39) NPSR1KDM4EKDRFLT1FLT4
SCHEMBL22925792 0.83 KDR (0.35) KDM4EKDRFLT1FLT4NPC1
SCHEMBL24637089 0.78 NPSR1 (0.38) NPSR1KDM4ETRPV1KDRFLT1
SCHEMBL22925781 0.77 KMT2A (0.36) NPSR1KDM4ETRPV1PTGS1NPC1
SCHEMBL22925941 0.77 KMT2A (0.36) NPSR1KDM4ETRPV1PTGS1NPC1
SCHEMBL29696311 0.77 KMT2A (0.36) NPSR1KDM4ETRPV1PTGS1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN claimed
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN disclosed
EP-4003986-A1 INHIBITOR COMPOUNDS Cincera Therapeutics Pty Ltd (AU) 2022-06-01 EP disclosed
CN-114450281-A Inhibitor compounds 辛塞拉治疗私人有限公司 2022-05-06 CN disclosed